In less than a decade, the search for common genetic variations that alter people’s risk of disease has changed the way we think about genetic risk. In the world of cardiovascular medicine, 36 single-nucleotide polymorphisms (SNPs)—the tiny genetic changes that help to differentiate one individual’s

In the recently released SCImago Institutions Rankings [SIR] World Report on the research impact of institutions and companies worldwide, the University of Ottawa Heart Institute placed 57th out of 3,042 organizations. The ranking, conducted by the SCImago Research Group, assessed the quality and

With roughly half a million Canadians now living with heart failure, the condition is an increasingly common one that can seriously impact an individual’s quality of life. Even when appropriately treated, hospital admission and readmission rates are stubbornly high. George Wells, Director of the

Dr. Frans Leenen is the Director of the Hypertension Clinic and Hypertension Research at the University of Ottawa Heart Institute. In 2008, he and fellow Heart Institute researcher Dr. George Fodor led the Ontario Survey on the Prevalence and Control of Hypertension, the most in-depth study of high

Julie Rutberg, Genetic Counsellor at the University of Ottawa Heart Institute since 2005, has been elected incoming President of the Canadian Association of Genetic Counsellors (CAGC). In her new position, she and the CAGC’s Board of Directors plan to tackle several big-picture questions about the

The State of the Science Lecture on Women and Heart Disease by Anne Rosenfeld of the Oregon Health Sciences University made it clear that there is much to learn about the ways the disease is unique to women. What we do know indicates that risk, symptoms, progression and treatment of CVD are all